Insider trade

Angiodynamics (ANGO): SVP Quality and Regulatory sold ~$50K

Warren Jr Nighan, SVP Quality and Regulatory at Angiodynamics, sold ~$50K of Angiodynamics shares.

~$50K
Approx. value · 4,060 sh @ $12.31: 42K
Holds after · shares reported

Traded: Jan 16, 2025
Filed: Jan 17, 2025

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Angiodynamics

For Angiodynamics, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ANGO page.

Other recent filings by Warren Jr Nighan, SVP Quality and Regulatory

The full history of Warren Jr Nighan, SVP Quality and Regulatory is on the profile page.

How this filing works

Explore the data

Other disclosures at Angiodynamics

Everything OQRO holds on this company is on its ANGO page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data